Informations générales (source: ClinicalTrials.gov)
Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Care of Patients Followed in Oncology for Cancer Within a Mobile Palliative Care Support Team (EMASP) (HYPNO-AROMA)
Observational
Centre Hospitalier Intercommunal Creteil (Voir sur ClinicalTrials)
avril 2024
octobre 2024
29 juin 2024
Patients having the following gestures (blood test, change of dressing for cancerous
lesion and complete toilet in bed) will be identified by the team of the medical oncology
department.
During the first contact (V0), the study will be presented to the patients in order to
obtain their consent. Anxiety and well-being will be assessed before performing the
gesture causing discomfort (gesture No.1). The gesture will then be performed and the
patient's comfort will be evaluated after the gesture is performed in order to obtain the
starting data for the study.
Patients will be reviewed in consultation according to the time recommended for each type
of gesture.
During the second contact V1 (between 1 and 9 days after D0) anxiety and well-being will
be assessed before performing the gesture causing discomfort (gesture No.2). Patients
will then be randomized. After randomization, the first hypnosis session will be
performed at the same time as gesture No. 2 and the patient's comfort will be evaluated
after the gesture is performed. The patient will receive the self-hypnosis training on
the same day.
A period of 7 ± 2 days will be considered for the learning time of self-hypnosis.
The third contact will take place on day D7+/-2 after V1. During this visit, anxiety and
well-being will be assessed before performing the gesture causing discomfort (gesture
No.3). Gesture No.3 will be carried out under the effect of self-hypnosis ± aromatherapy
and the measurement of comfort will be carried out immediately afterwards
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHI DE CRETEIL | Lambert Vadrot | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients aged ≥18 years
- Patients followed in medical oncology and by the mobile palliative care support team
- From the first line of chemotherapy
- Patient requiring one of the following procedures:
- Blood test
- Change of dressing for cancerous lesion
- Complete toilet in bed
- Patients who have given their consent
- Patient affiliated with a social security scheme
- Patients aged ≥18 years
- Patients followed in medical oncology and by the mobile palliative care support team
- From the first line of chemotherapy
- Patient requiring one of the following procedures:
- Blood test
- Change of dressing for cancerous lesion
- Complete toilet in bed
- Patients who have given their consent
- Patient affiliated with a social security scheme
- Protected person under guardianship or curatorship,
- Person deprived of liberty
- Person unable to express consent
- Pregnant woman and breastfeeding woman
- History of allergy or intolerance to essential oils
- Patients with cognitive or language disorders that make it impossible to answer the
questionnaires
- Psychotic disorders